Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38302 NRX PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 82-2844431 (Sta ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended: December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38302 NRX PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 82-2844431 (State or ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Suzanne Messere - IR Stephen Willard - CEO Seth Van Voorhees - CFO Jonathan Javitt - Chief Scientist Conference Call Participants Jason Kolbert - Dawson James Vernon Bernadino - H.C. Wainwright Ed Woo - Ascendiant Capital Operator Good afternoon and welcome to the NRx Pharmaceuticals Full Year 2022 Results Conference Call. All participants will be in a listen-only mode. [Operator Instructi ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2022 Earnings Conference Call November 14, 2022 8:00 AM ET Company Participants Suzanne Messere - Investor Relations Stephen Willard - Chief Executive Officer Seth Van Voorhees - Chief Financial Officer and Treasurer Jonathan Javitt - Founder and Chief Scientist Conference Call Participants Vernon Bernadino - H.C. Wainwright Ed Woo - Ascendiant Capital Operator Good morning, and welcome to the NRx Pharmaceuticals Third Quarter 2022 Earnings Conference Call. All par ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2022 Earnings Conference Call August 15, 2022 8:30 AM ET Company Participants Tom Johnson - Investor Relations Stephen Willard - Chief Executive Officer Seth Van Voorhees - Chief Financial Officer & Treasurer Robert Besthof - Head of Operations & Chief Commercial Officer Conference Call Participants Vernon Bernardino - HC Wainwright Operator Good day, and welcome to the NRx Pharmaceuticals Second Quarter 2022 Conference Call. All participants will be in a listen-on ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Robert Besthof ??? Interim Chief Executive Officer, Head of Operations & Chief Commercial Officer Tom Johnson ??? Investor Relations Ira Strassberg ??? Chief Financial Officer and Treasurer Conference Call Participants Operator Greetings and welcome to NRX Pharmaceuticals First Quarter 2022, Earnings Conference Call. At this time, all participants are in listen-only mode. [Operator Instructi ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2021 Earnings Conference Call March 31, 2022 8:30 AM ET Company Participants Eric Goldstein - MD, LifeSci Advisors, IR Robert Besthof - Interim CEO, Head of Operations & Chief Commercial Officer Ira Strassberg - CFO and Treasurer Conference Call Participants Operator Greetings and welcome to the NRx Pharmaceuticals Full Year 2021 Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2021 Earnings Conference Call November 16, 2021 8:30 AM ET Company Participants Eric Goldstein - Managing Director, LifeSci Advisors Jonathan Javitt - Chairman and Chief Executive Officer Randy Guggenheimer - Chief Business Officer Operator Good morning, everyone and welcome to the NRx Pharmaceuticals??? Third Quarter Results and Conference Call. Currently, participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference call is being ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2021 Results Conference Call August 17, 2021 8:30 AM ET Company Participants Eric Goldstein - Managing Director, LifeSci Advisors Jonathan Javitt - Chairman and Chief Executive Officer Randy Guggenheimer - Chief Business Officer Robert Besthof - Chief Commercial Officer Operator Greetings, and welcome to the NRx Pharma Second Quarter 2021 Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal pr ...